Electrophysiology Market: Growth, Size, Share, and Trends
Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording, ICE, X-ray Systems), Ablation Catheters (Cryoablation, Radiofrequency, Laser, Microwave), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), End Use-Global Forecast to 2030
USD 21.72 BN
MARKET SIZE, 2030
CAGR 11.6%
(2025-2030)
330
REPORT PAGES
322
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The electrophysiology market is projected to reach USD 21.72 billion by 2030 from USD 12.55 billion in 2025, at a CAGR of 11.6% from 2025 to 2030. The growth of the electrophysiology market is driven by the the rising prevalence of cardiac arrhythmias, increasing technological innovations in advanced electrophysiological devices , and high geriatric population.
KEY TAKEAWAYS
-
BY PRODUCTThe electrophysiology market comprises electrophysiology laboratory devices, electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology access devices, and other electrophysiology devices. Electrophysiology ablation catheters was the largest segment due to the increasing adoption of catheter ablation as a preferred treatment for arrhythmias and technological advancements such as contact-force sensing, high-density mapping, and the development of cryoablation and laser ablation techniques
-
BY INDICATIONKey indications include atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-White syndrome (WPW), and other indications. Atrial fibrillation is projected to witness the highest CAGR throughout the forecast period, largely attributable to the increasing prevalence of risk factors such as hypertension and diabetes.
-
BY END USERIn the electrophysiology market, hospitals & cardiac centers lead in demand due to rising prevalence of cardiac arrhythmias and complex cardiovascular conditions that demands for dedicated EP services, followed by ambulatory surgery centers and other end users.
-
BY REGIONThe aerospace materials market covers North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America has the largest share for the electrophysiology market due the increasing prevalence of cardiac arrhythmias, well-established healthcare infrastructure, and a high rate of adoption of cutting-edge technologies that enhance diagnostic and treatment capabilities.
-
COMPETITIVE LANDSCAPEMajor market players have adopted both organic and inorganic strategies, including partnerships and investments. For instance, Johnson & Johnson Services, Inc. (US), Abbott (US), Medtronic (Ireland), have entered into a number of agreements and partnerships to enhance the development of advanced electrophysiology devices, expand their product portfolios, and cater to the growing demand for innovative treatments in arrhythmia management.
The electrophysiology market is witnessing steady growth, driven by the increasing prevalence of cardiac arrhythmias, rising adoption of advanced diagnostic and therapeutic devices, and growing awareness of heart health. New developments, including innovations in catheter-based ablation technologies, wearable monitoring devices, and strategic collaborations between medical device companies and healthcare providers, are reshaping the industry landscape.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The Electrophysiology market is undergoing a significant transformation driven by technological, regulatory, and healthcare delivery trends. A key disruption is the increasing shift toward noninvasive and continuous monitoring solutions, spurred by growing demand for remote patient care and chronic disease management, especially for cardiovascular and respiratory conditions.|
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Technological innovations for advanced, effective, and easy-to-use electrophysiological devices
-
High geriatric population and increased prevalence of cardiovascular diseases
RESTRAINTS
Impact
Level
Level
-
High product cost and inadequate reimbursement in developing and under-resourced healthcare settings
-
Unfavorable healthcare reforms in US
OPPORTUNITIES
Impact
Level
Level
-
Substantial growth opportunities in emerging economies
-
Popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services
CHALLENGES
Impact
Level
Level
-
Global shortage of skilled and experienced personnel
-
High treatment costs and complexity of procedures
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Technological innovations for advanced, effective, and easy-to-use electrophysiological devices
Technological advancements are pivotal in accelerating the electrophysiology market's growth by enabling more accurate diagnosis, precise treatment, and improved patient outcomes. A major innovation has been the development of advanced 3D electro-anatomical mapping systems, which create high-resolution, real-time maps of the heart's electrical activity. Additionally,robot-assisted electrophysiology procedures are becoming more prevalent in specialized centers.
Restraint: High product cost and inadequate reimbursement in developing and under-resourced healthcare settings
One of the main barriers to the growth of the electrophysiology market is the high cost of EP equipment, technologies, and procedures. Electrophysiology labs need advanced infrastructure, such as state-of-the-art 3D electro-anatomical mapping systems, ablation generators, fluoroscopy units, intracardiac echocardiography (ICE) machines, and high-precision catheters—each with a substantial price tag.
Opportunity: Substantial growth opportunities in emerging economies
Emerging markets—India, Brazil, Mexico, Indonesia, and South Africa—offer significant growth opportunities for electrophysiology. With rising GDP, increasing urbanization, and government efforts to enhance healthcare infrastructure, these countries are seeing a boost in healthcare investments. Many emerging countries are skipping older technologies and directly adopting next-generation solutions, such as 3D mapping, contact-force sensing catheters, and cryoablation.
Challenge: Global shortage of skilled and experienced personnel
Despite the growing demand for electrophysiology services, a critical shortage of skilled professionals remains a pressing challenge worldwide, particularly in developing and under-resourced settings. Electrophysiology is a highly specialized field within cardiology, requiring extensive training in advanced mapping, ablation techniques, and interpretation of complex cardiac signals. Additionally, the lack of training centers, standardized EP curricula, and limited hands-on exposure further hinders the ability to scale the workforce.
Electrophysiology Market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Utilizes TactiCath Contact Force Ablation Catheter with integrated force sensing for atrial fibrillation procedures. | Enables precise lesion formation, reduces recurrence rates, and improves procedural safety. |
 |
CARTO 3 System for advanced 3D electroanatomical cardiac mapping. | Provides real-time visualization, enhances navigation accuracy, and minimizes fluoroscopy exposure. |
 |
AcQMap High-Resolution Imaging and Mapping System using ultrasound and charge density mapping. | Enables comprehensive visualization of arrhythmia patterns and improves treatment precision. |
 |
Farapulse Pulsed Field Ablation (PFA) System for atrial fibrillation (AF) treatment. | Offers precise tissue ablation with minimal collateral damage, reducing procedure time and enhancing safety. |
 |
PulseSelect PFA System for AF ablation. | Provides targeted energy delivery, improving procedural efficiency and patient outcomes. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem of the electrophysiology (EP) market is composed of a complex network of stakeholders that collectively drive innovation, product development, clinical adoption, and market growth. At the core are medical device manufacturers such as Johnson & Johnson Services, Inc., Abbott, Medtronic, and Boston Scientific Corporation, which lead in producing advanced technologies such as 3D cardiac mapping systems, ablation catheters, diagnostic electrodes, and recording systems. Supporting them are software and Al developers specializing in real-time signal processing, arrhythmia detection, and integrated procedural planning, many of whom partner with device OEMs to embed intelligent solutions into EP platforms).
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Electrophysiology Market, By Product
As of 2024, electrophysiology ablation catheters held the largest share of the electrophysiology market due to the convergence of clinical, technological, and healthcare system factors. A key factor is the increasing clinical acceptance of catheter ablation as a first-line treatment for arrhythmias, especially atrial fibrillation, supported by evolving clinical guidelines and robust outcomes data. Technological innovations, such as high-resolution mapping systems and integration with advanced imaging modalities, have greatly improved procedural accuracy and outcomes, encouraging wider adoption.
Electrophysiology Market, By Indication
In 2024, atrial fibrillation (AF) dominated the electrophysiological market, driven by the increasing global demographic of aging individuals, alongside rising rates of obesity, hypertension, diabetes, and sedentary behaviors, has led to a notable surge in AF prevalence. This growing burden of AF is driving heightened demand for EP diagnostics and therapeutic interventions. Moreover, significant advancements in EP procedural techniques, such as enhanced catheter ablation methods, state-of-the-art mapping systems, and sophisticated intracardiac imaging technologies, have markedly improved both the efficacy and safety profiles of interventions.
Electrophysiology Market, By End User
The hospitals & cardiac centers segment is expected to dominate the eletrophysiological market, hospitals integrate electrophysiology services into their cardiology departments, enabling cardiologists, electrophysiologists, and other healthcare providers to collaborate more effectively. These institutions are equipped with the necessary infrastructure, advanced technologies, and skilled professionals required for performing electrophysiology procedures such as catheter ablation. With high patient demand for comprehensive cardiac care, hospitals and cardiac centers serve as the primary providers for diagnosing and treating arrhythmias and other heart diseases.
REGION
Asia Pacific to be fastest-growing region in global electrophysiology market during forecast period
The Asia Pacific electrophysiology market is expected to register the highest CAGR during the forecast period, driven by a large population, an increasing geriatric population, the growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, increasing demand for advanced technologies, the growing emphasis of prominent players on emerging markets, and less stringent regulations are also fueling the demand for electrophysiology devices in this region. Changing lifestyles and eating habits, increasing stress, and rising habitual smoking & drinking in these countries have resulted in growing health-related problems such as obesity, heart disease, and other chronic diseases, which further boosts growth of the market.
Electrophysiology Market: COMPANY EVALUATION MATRIX
In the electrophysiology market matrix, Johnson & Johnson Services, Inc. (Star) leads with a strong market share and extensive product portfolio, driven by its advanced electrophysiology devices which are widely adopted for treating arrhythmias in both commercial and clinical settings. The company’s dominance is supported by its robust research capabilities, broad distribution network, and strong brand reputation in the cardiovascular space. Stereotaxis, Inc. (Emerging Leader) is gaining visibility with its robotic navigation systems and innovative solutions for electrophysiology procedures which enhances precision in catheter-based ablation. Stereotaxis is strengthening its position through continuous innovation, partnerships, and a growing adoption of its robotic-assisted technologies. While Johnson & Johnson dominates with its scale and comprehensive product offerings, Stereotaxis shows significant potential to move toward the leaders’ quadrant as demand for minimally invasive, precision-driven electrophysiology procedures continues to rise.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 11.41 Billion |
| Market Forecast in 2030 (Value) | USD 21.72 Billion |
| Growth Rate | CAGR of 11.6% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million/Billion), Volume (Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: Electrophysiology Market REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Comparison of leading electrophysiology devices:Electrophysiology Laboratory Devices, Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Access Devices. Electrophysiology Ablation Catheters dominate due to their essential role in minimally invasive arrhythmia treatment, high success rates, and continuous technological advancements enhancing precision and safety. | Enables identification of product adoption shifts across care settings; Detects safety and compliance-related trends impacting purchasing. |
| Company Information | Key players: Johnson & Johnson Services, Inc., Abbott, Koninklijke Philips N.V., Medtronic and GE Healthcare. Top 3-5 players market share analysis at APAC and European country level. | Insights on revenue shifts towards emerging therapeutic applications and device innovations. |
| Geographic Analysis | Detailed analysis on Rest of APAC was provided to one of the top players. Client focused on ASEAN Market country level analysis for device market. | Country level demand mapping for new product launches and localization strategy planning. |
RECENT DEVELOPMENTS
- November 2024 : Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform for the treatment of drug-refractory paroxysmal Atrial Fibrillation (AFib).
- November 2024 : Abbott, the global healthcare company announced the launch of AVEIR VR single-chamber ventricular leadless pacemaker for the treatment of patients in India with slow heart rhythms. This pacemaker is now approved by Central Drugs Standard Control Organization (CDSCO) in India.
- October 2024 : Medtronic announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density (HD) mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter for treatment of persistent atrial fibrillation (AFib) and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
30
2
RESEARCH METHODOLOGY
35
3
EXECUTIVE SUMMARY
49
4
PREMIUM INSIGHTS
52
5
MARKET OVERVIEW
Electrophysiology market thrives on AI, digital tech, and emerging economies despite cost challenges.
55
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
TECHNOLOGICAL INNOVATIONS FOR ADVANCED, EFFECTIVE, AND EASY-TO-USE ELECTROPHYSIOLOGICAL DEVICES
5.2.1.2
HIGH GERIATRIC POPULATION AND INCREASED PREVALENCE OF CARDIOVASCULAR DISEASES
5.2.1.3
RISING INVESTMENTS, FUNDS, AND GRANTS FOR CARDIAC SURGERIES AND ELECTROPHYSIOLOGY
5.2.1.4
INCREASING CARDIOVASCULAR DISEASE INCIDENCE AND PROCEDURAL VOLUME
5.2.2
RESTRAINTS
5.2.2.1
HIGH PRODUCT COST AND INADEQUATE REIMBURSEMENT IN DEVELOPING AND UNDER-RESOURCED HEALTHCARE SETTINGS
5.2.2.2
UNFAVORABLE HEALTHCARE REFORMS IN US
5.2.3
OPPORTUNITIES
5.2.3.1
SUBSTANTIAL GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
5.2.3.2
POPULARITY OF AMBULATORY SURGICAL CENTERS OFFERING COST-EFFECTIVE OUTPATIENT ELECTROPHYSIOLOGY SERVICES
5.2.4
CHALLENGES
5.2.4.1
GLOBAL SHORTAGE OF SKILLED AND EXPERIENCED PERSONNEL
5.3
INDUSTRY TRENDS
5.3.1
INTEGRATION OF DIGITAL TECHNOLOGIES, ARTIFICAL INTELLIGENCE, AND REMOTE MONITORING IN ELECTROPHYSIOLOGY
5.3.2
ROBOTIC-ASSISTED ABLATION AND NAVIGATION TECHNOLOGIES FOR BETTER TRACTION IN ELECTROPHYSIOLOGY
5.4
TECHNOLOGY ANALYSIS
5.4.1
KEY TECHNOLOGIES
5.4.1.1
3D MAPPING AND NAVIGATION SYSTEMS
5.4.1.2
CRYOABLATION AND RADIOFREQUENCY ABLATION TECHNOLOGIES
5.4.2
COMPLEMENTARY TECHNOLOGIES
5.4.2.1
CARDIAC IMAGING TECHNOLOGIES
5.4.2.2
ROBOTIC NAVIGATION SYSTEMS
5.4.3
ADJACENT TECHNOLOGIES
5.4.3.1
AI-ENABLED INTRAVASCULAR OPTICAL COHERENCE TOMOGRAPHY (OCT)
5.4.3.2
AI-DRIVEN VIEW GUIDANCE IN INTRA-CARDIAC ECHOCARDIOGRAPHY (ICE)
5.5
PORTER’S FIVE FORCES ANALYSIS
5.5.1
INTENSITY OF COMPETITIVE RIVALRY
5.5.2
BARGAINING POWER OF BUYERS
5.5.3
BARGAINING POWER OF SUPPLIERS
5.5.4
THREAT OF SUBSTITUTES
5.5.5
THREAT OF NEW ENTRANTS
5.6
KEY STAKEHOLDERS & BUYING CRITERIA
5.6.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.6.2
KEY BUYING CRITERIA
5.7
REGULATORY ANALYSIS
5.7.1
REGULATORY FRAMEWORK
5.7.1.1
NORTH AMERICA
5.7.1.2
EUROPE
5.7.1.3
ASIA PACIFIC
5.7.1.4
LATIN AMERICA
5.7.1.5
MIDDLE EAST & AFRICA
5.7.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8
REIMBURSEMENT SCENARIO ANALYSIS
5.9
PATENT ANALYSIS
5.9.1
PATENT PUBLICATION TRENDS FOR ELECTROPHYSIOLOGY MARKET
5.9.2
LIST OF KEY PATENTS
5.10
TRADE ANALYSIS
5.10.1
IMPORT DATA FOR HS CODE 901890, 2020−2024
5.10.2
EXPORT DATA FOR HS CODE 901890, 2020−2024
5.11
PRICING ANALYSIS
5.11.1
INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022–2024
5.11.2
AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022–2024
5.12
KEY CONFERENCES & EVENTS, 2025−2026
5.13
UNMET NEEDS & END-USER EXPECTATIONS
5.14
VALUE CHAIN ANALYSIS
5.15
SUPPLY CHAIN ANALYSIS
5.16
ECOSYSTEM ANALYSIS
5.17
CASE STUDY ANALYSIS
5.17.1
JOHNSON & JOHNSON TO EXPAND CARTO SUITE AND LEVERAGE AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING
5.17.2
ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY
5.17.3
PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT
5.18
ADJACENT MARKET ANALYSIS
5.19
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.20
INVESTMENT & FUNDING SCENARIO
5.21
IMPACT OF AI/GEN AI ON ELECTROPHYSIOLOGY MARKET
5.22
IMPACT OF 2025 US TARIFF ON ELECTROPHYSIOLOGY MARKET
5.22.1
KEY TARIFF RATES
5.22.2
PRICE IMPACT ANALYSIS
5.22.3
IMPACT ON COUNTRY/REGION
5.22.3.1
NORTH AMERICA
5.22.3.2
EUROPE
5.22.3.3
ASIA PACIFIC
5.22.4
IMPACT ON END-USE INDUSTRIES
5.22.4.1
HOSPITALS & CLINICS
5.22.4.2
AMBULATORY SURGERY CENTERS
6
ELECTROPHYSIOLOGY MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 23 Data Tables
100
6.1
INTRODUCTION
6.2
ELECTROPHYSIOLOGY LABORATORY DEVICES
6.2.1
3D MAPPING SYSTEMS
6.2.1.1
DEVELOPMENT OF ALTERNATIVE TECHNOLOGIES TO LIMIT MARKET GROWTH
6.2.2
ELECTROPHYSIOLOGY RECORDING SYSTEMS
6.2.2.1
INCREASING PUBLIC-PRIVATE FUNDING FOR DEVELOPING ADVANCED NOVEL RECORDING SYSTEMS TO AUGMENT MARKET GROWTH
6.2.3
RADIOFREQUENCY (RF) ABLATION SYSTEMS
6.2.3.1
COST-EFFECTIVENESS AND TECHNOLOGICAL ADVANCEMENTS TO SPUR SEGMENT GROWTH
6.2.4
INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS
6.2.4.1
RISING LIFESTYLE- AND AGE-RELATED DISORDERS TO DRIVE ADOPTION FOR CARDIAC DISEASE TREATMENT
6.2.5
ELECTROPHYSIOLOGY X-RAY SYSTEMS
6.2.5.1
HIGH INCIDENCE OF CARDIOVASCULAR DISORDERS AND AVAILABILITY OF TECHNOLOGICALLY ADVANCED EQUIPMENT TO BOOST MARKET GROWTH
6.2.6
REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS
6.2.6.1
FAVORABLE REIMBURSEMENT SCENARIO TO PROPEL MARKET GROWTH
6.3
ELECTROPHYSIOLOGY ABLATION CATHETERS
6.3.1
CRYOABLATION CATHETERS
6.3.1.1
THERAPEUTIC ADVANTAGES AND BETTER CLINICAL STUDIES TO DRIVE MARKET GROWTH
6.3.2
RADIOFREQUENCY (RF) ABLATION CATHETERS
6.3.2.1
TECHNOLOGICALLY-ADVANCED AND SAFER CATHETERS TO DRIVE ADOPTION AMONG HEALTHCARE PROFESSIONALS
6.3.3
MICROWAVE ABLATION (MWA) CATHETERS
6.3.3.1
SMALLER DIAMETER ANTENNAS, FASTER PROCEDURE TIMES, AND LARGER HEATING ZONES TO AID MARKET GROWTH
6.3.4
LASER ABLATION CATHETERS
6.3.4.1
LAUNCH OF TECHNOLOGICALLY-ADVANCED LASER ABLATION CATHETERS TO DRIVE ADOPTION IN HEALTHCARE SETTINGS
6.4
ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1
CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1.1
DEVELOPMENT OF TECHNOLOGICALLY-ADVANCED FIXED AND STEERABLE DIAGNOSTIC CATHETERS TO FAVOR MARKET GROWTH
6.4.2
ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.2.1
ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS TO IMPROVE PATIENT OUTCOMES AND OPTIMIZE SURGICAL PROCEDURES
6.4.3
ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.3.1
AVAILABILITY OF ADVANCED ULTRASOUND CATHETERS AND FOCUS ON SUPPORTIVE REGULATORY FRAMEWORKS TO DRIVE SEGMENT
6.5
ELECTROPHYSIOLOGY ACCESS DEVICES
6.5.1
LAUNCH OF ADVANCED ACCESS DEVICES TO ENHANCE EFFICIENCY DURING ABLATION CATHETER MAPPING AND POSITIONING
6.6
OTHER ELECTROPHYSIOLOGY PRODUCTS
7
ELECTROPHYSIOLOGY MARKET, BY INDICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
129
7.1
INTRODUCTION
7.2
ATRIAL FIBRILLATION
7.2.1
DEVELOPMENT OF ADVANCED CARDIAC MAPPING SYSTEMS FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET
7.3
ATRIAL FLUTTER
7.3.1
HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATING ATRIAL FLUTTER TO PROPEL MARKET GROWTH
7.4
ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
7.4.1
INCREASING EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR TREATMENT OF AVNRT TO AID MARKET GROWTH
7.5
WOLFF-PARKINSON-WHITE (WPW) SYNDROME
7.5.1
PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO AUGMENT MARKET GROWTH
7.6
OTHER INDICATIONS
8
ELECTROPHYSIOLOGY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
139
8.1
INTRODUCTION
8.2
HOSPITALS & CARDIAC CENTERS
8.2.1
PRESENCE OF BETTER CATHETERIZATION AND ELECTROPHYSIOLOGY LABORATORIES IN HOSPITALS TO SUPPORT MARKET GROWTH
8.3
AMBULATORY SURGERY CENTERS
8.3.1
DEMAND FOR MINIMAL HOSPITAL STAYS AND HIGH INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH
8.4
OTHER END USERS
9
ELECTROPHYSIOLOGY MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 16 Countries | 188 Data Tables.
145
9.1
INTRODUCTION
9.2
NORTH AMERICA
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2
US
9.2.2.1
US TO DOMINATE NORTH AMERICAN ELECTROPHYSIOLOGY MARKET DURING FORECAST PERIOD
9.2.3
CANADA
9.2.3.1
GROWING GOVERNMENT RESEARCH FUNDING TO SUPPORT MARKET GROWTH
9.3
EUROPE
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2
GERMANY
9.3.2.1
RISING PREVALENCE OF ATRIAL FIBRILLATION AND ASSOCIATED ARRHYTHMIAS TO PROPEL MARKET GROWTH
9.3.3
UK
9.3.3.1
HIGH GERIATRIC POPULATION AND RISE IN CARDIAC DISEASES TO FUEL MARKET GROWTH
9.3.4
FRANCE
9.3.4.1
FAVORABLE GOVERNMENT HEALTHCARE POLICIES AND SCHEMES TO SUPPORT MARKET GROWTH
9.3.5
ITALY
9.3.5.1
RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES
9.3.6
SPAIN
9.3.6.1
RISING NUMBER OF CARDIAC ABLATION PROCEDURES TO DRIVE ADOPTION OF ELECTROPHYSOIOLOGY PRODUCTS
9.3.7
REST OF EUROPE
9.4
ASIA PACIFIC
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2
JAPAN
9.4.2.1
FAVORABLE REIMBURSEMENT SCENARIO AND PRESENCE OF UNIVERSAL HEALTHCARE POLICIES TO BOOST MARKET GROWTH
9.4.3
CHINA
9.4.3.1
GROWING GERIATRIC POPULATION AND RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH
9.4.4
INDIA
9.4.4.1
FAVORABLE GOVERNMENT HEALTHCARE INITIATIVES TO SUPPORT MARKET GROWTH
9.4.5
AUSTRALIA
9.4.5.1
INCREASING TARGET DISEASE BURDEN AND RISING GOVERNMENT FUNDING TO SPUR MARKET GROWTH
9.4.6
SOUTH KOREA
9.4.6.1
SUPPORTIVE GOVERNMENT INITIATIVES TO DRIVE MARKET
9.4.7
REST OF ASIA PACIFIC
9.5
LATIN AMERICA
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2
BRAZIL
9.5.2.1
MODERNIZATION OF HEALTHCARE FACILITIES TO PROPEL MARKET GROWTH
9.5.3
MEXICO
9.5.3.1
FAVORABLE INVESTMENT SCENARIO FOR MEDICAL DEVICE MANUFACTURERS TO FUEL MARKET GROWTH
9.5.4
REST OF LATIN AMERICA
9.6
MIDDLE EAST & AFRICA
9.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2
GCC COUNTRIES
9.6.2.1
KINGDOM OF SAUDI ARABIA
9.6.2.2
UAE
9.6.2.3
REST OF GCC COUNTRIES
9.6.3
REST OF MIDDLE EAST & AFRICA
10
COMPETITIVE LANDSCAPE
Discover winning strategies and market dynamics shaping the electrophysiology competitive landscape.
249
10.1
INTRODUCTION
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ELECTROPHYSIOLOGY MARKET
10.3
REVENUE ANALYSIS, 2020–2024
10.4
MARKET SHARE ANALYSIS, 2024
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1
STARS
10.5.2
EMERGING LEADERS
10.5.3
PERVASIVE PLAYERS
10.5.4
PARTICIPANTS
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1
COMPANY FOOTPRINT
10.5.5.2
REGION FOOTPRINT
10.5.5.3
PRODUCT FOOTPRINT
10.5.5.4
INDICATION FOOTPRINT
10.5.5.5
END-USER FOOTPRINT
10.6
COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2024
10.6.1
PROGRESSIVE COMPANIES
10.6.2
RESPONSIVE COMPANIES
10.6.3
DYNAMIC COMPANIES
10.6.4
STARTING BLOCKS
10.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
10.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
10.7
COMPANY VALUATION & FINANCIAL METRICS
10.7.1
FINANCIAL METRICS
10.7.2
COMPANY VALUATION
10.8
BRAND/PRODUCT COMPARISON
10.9
R&D ASSESSMENT OF KEY PLAYERS
10.10
COMPETITIVE SCENARIO
10.10.1
PRODUCT LAUNCHES & APPROVALS
10.10.2
DEALS
10.10.3
OTHER DEVELOPMENTS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
267
11.1
KEY PLAYERS
11.1.1
JOHNSON & JOHNSON SERVICES, INC.
11.1.1.1
BUSINESS OVERVIEW
11.1.1.2
PRODUCTS OFFERED
11.1.1.3
RECENT DEVELOPMENTS
11.1.1.4
MNM VIEW
11.1.2
ABBOTT
11.1.3
MEDTRONIC
11.1.4
KONINKLIJKE PHILIPS N.V.
11.1.5
GE HEALTHCARE
11.1.6
BOSTON SCIENTIFIC CORPORATION
11.1.7
JAPAN LIFELINE CO., LTD.
11.1.8
STEREOTAXIS, INC.
11.1.9
MICROPORT SCIENTIFIC CORPORATION
11.1.10
BIOTRONIK
11.1.11
TELEFLEX INCORPORATED
11.1.12
ACUTUS MEDICAL, INC.
11.1.13
MERIT MEDICAL SYSTEMS
11.1.14
OSYPKA MEDICAL
11.1.15
COOK
11.2
OTHER PLAYERS
11.2.1
EPMAP-SYSTEM
11.2.2
CATHRX LTD.
11.2.3
EP SOLUTIONS
11.2.4
CATHVISION
11.2.5
TZ MEDICAL, INC.
11.2.6
APN HEALTH, LLC
11.2.7
LEPU MEDICAL TECHNOLOGY (BEIJING) CO.,LTD.
11.2.8
CARDIOFOCUS
11.2.9
SCHWARZER CARDIOTEK
11.2.10
IMRICOR
12
APPENDIX
321
12.1
DISCUSSION GUIDE
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
12.4
RELATED REPORTS
12.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
ELECTROPHYSIOLOGY MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES, 2021–2024 (UNIT OF USD)
TABLE 3
ELECTROPHYSIOLOGY MARKET: STUDY ASSUMPTIONS
TABLE 4
ELECTROPHYSIOLOGY MARKET: RISK ANALYSIS
TABLE 5
GLOBAL ANNUAL CARDIAC SURGICAL VOLUMES PER 100,000 POPULATION (2023)
TABLE 6
MAJOR FUNDING BY KEY ORGANIZATIONS, 2023–2024
TABLE 7
ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES
TABLE 8
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
TABLE 9
KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY SYSTEMS
TABLE 10
US FDA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 11
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 12
CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2024)
TABLE 13
JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
TABLE 14
CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
ELECTROPHYSIOLOGY MARKET: CPT CODES
TABLE 19
ELECTROPHYSIOLOGY MARKET: LIST OF KEY PATENTS, 2025
TABLE 20
IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020−2024 (USD THOUSAND)
TABLE 21
EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020−2024 (USD THOUSAND)
TABLE 22
INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022–2024 (USD THOUSAND)
TABLE 23
AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022–2024 (USD THOUSAND)
TABLE 24
ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026
TABLE 25
ELECTROPHYSIOLOGY MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 26
CASE STUDY 1: JOHNSON & JOHNSON TO EXPAND CARTO SUITE FOR LEVERAGING AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING
TABLE 27
CASE STUDY 2: ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY
TABLE 28
CASE STUDY 3: PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT
TABLE 29
ELECTROPHYSIOLOGY MARKET: IMPACT OF AI/GEN AI
TABLE 30
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 31
KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ELECTROPHYSIOLOGY PRODUCTS
TABLE 32
ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 33
ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34
ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35
3D MAPPING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
RADIOFREQUENCY (RF) ABLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40
REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 42
ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
CRYOABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
RADIOFREQUENCY (RF) ABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
COMPARISON BETWEEN RADIOFREQUENCY ABLATION AND MICROWAVE ABLATION (MWA) CATHETERS
TABLE 46
MICROWAVE ABLATION (MWA) CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
LASER ABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 49
ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 56
ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58
ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT), BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE (WPW) SYNDROME, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 62
ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64
ELECTROPHYSIOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
ELECTROPHYSIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 68
NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 69
NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS)
TABLE 70
NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 71
NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 72
NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 73
NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 74
US: KEY MACROINDICATORS
TABLE 75
US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 76
US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 77
US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 78
US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 79
US: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 80
US: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 81
CANADA: KEY MACROINDICATORS
TABLE 82
CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 83
CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 84
CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 85
CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86
CANADA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 87
CANADA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 88
EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89
EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 90
EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91
EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS)
TABLE 92
EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 93
EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 94
EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 95
EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 96
GERMANY: KEY MACROINDICATORS
TABLE 97
GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 98
GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99
GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 100
GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101
GERMANY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 102
GERMANY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 103
UK: KEY MACROINDICATORS
TABLE 104
UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 105
UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106
UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
UK: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 109
UK: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 110
FRANCE: KEY MACROINDICATORS
TABLE 111
FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 112
FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114
FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
FRANCE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 116
FRANCE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 117
ITALY: KEY MACROINDICATORS
TABLE 118
ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 119
ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120
ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
ITALY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 123
ITALY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 124
SPAIN: KEY MACROINDICATORS
TABLE 125
SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 126
SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 128
SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
SPAIN: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 130
SPAIN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 131
REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 132
REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 135
REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 136
REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 137
ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138
ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 139
ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS)
TABLE 141
ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 143
ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 144
ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 145
JAPAN: KEY MACROINDICATORS
TABLE 146
JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 147
JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 150
JAPAN: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 151
JAPAN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 152
CHINA: KEY MACROINDICATORS
TABLE 153
CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 154
CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
CHINA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 158
CHINA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 159
INDIA: KEY MACROINDICATORS
TABLE 160
INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 161
INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 164
INDIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 165
INDIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 166
AUSTRALIA: KEY MACROINDICATORS
TABLE 167
AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 168
AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 172
AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 173
SOUTH KOREA: KEY MACROINDICATORS
TABLE 174
SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 175
SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 179
SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 180
REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 181
REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 184
REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 185
REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 186
LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 187
LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 188
LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS)
TABLE 190
LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 193
LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 194
BRAZIL: KEY MACROINDICATORS
TABLE 195
BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 196
BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
BRAZIL: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 200
BRAZIL: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 201
MEXICO: KEY MACROINDICATORS
TABLE 202
MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 203
MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 205
MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
MEXICO: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 207
MEXICO: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 208
REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 209
REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 210
REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 213
REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 214
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 215
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 216
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS)
TABLE 218
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 221
MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 222
GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 223
GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 224
GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 228
GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 229
KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 230
KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231
KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 234
KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 235
UAE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 236
UAE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 237
UAE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
UAE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
UAE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 240
UAE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 241
REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 242
REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243
REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245
REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 246
REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 247
REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 248
REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249
REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251
REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION)
TABLE 252
REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 253
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET
TABLE 254
ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION
TABLE 255
ELECTROPHYSIOLOGY MARKET: REGION FOOTPRINT
TABLE 256
ELECTROPHYSIOLOGY MARKET: PRODUCT FOOTPRINT
TABLE 257
ELECTROPHYSIOLOGY MARKET: INDICATION FOOTPRINT
TABLE 258
ELECTROPHYSIOLOGY MARKET: END-USER FOOTPRINT
TABLE 259
ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 260
ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
TABLE 261
ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025
TABLE 262
ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2022–MAY 2025
TABLE 263
ELECTROPHYSIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
TABLE 264
JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
TABLE 265
JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
TABLE 266
JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025
TABLE 267
JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–MAY 2025
TABLE 268
ABBOTT: COMPANY OVERVIEW
TABLE 269
ABBOTT: PRODUCTS OFFERED
TABLE 270
ABBOTT: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 271
ABBOTT: DEALS, JANUARY 2022–MAY 2025
TABLE 272
MEDTRONIC: COMPANY OVERVIEW
TABLE 273
MEDTRONIC: PRODUCTS OFFERED
TABLE 274
MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–MAY 2025
TABLE 275
MEDTRONIC: DEALS, JANUARY 2022–MAY 2025
TABLE 276
KONINKIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 277
KONINKIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 278
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MAY 2025
TABLE 279
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 280
GE HEALTHCARE: PRODUCTS OFFERED
TABLE 281
GE HEALTHCARE: PRODUCT APPROVALS AND ENHANCEMENTS, JANUARY 2022–MAY 2025
TABLE 282
GE HEALTHCARE: DEALS, JANUARY 2022–MAY 2025
TABLE 283
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 284
BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 285
BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2022–MAY 2025
TABLE 286
BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–MAY 2025
TABLE 287
JAPAN LIFELINE CO., LTD.: COMPANY OVERVIEW
TABLE 288
JAPAN LIFELINE CO., LTD.: PRODUCTS OFFERED
TABLE 289
STEREOTAXIS, INC.: COMPANY OVERVIEW
TABLE 290
STEREOTAXIS, INC.: PRODUCTS OFFERED
TABLE 291
STEREOTAXIS, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025
TABLE 292
STEREOTAXIS, INC.: DEALS, JANUARY 2022–MAY 2025
TABLE 293
MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 294
MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 295
MICROPORT SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2022–MAY 2025
TABLE 296
MICROPORT SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
TABLE 297
BIOTRONIK: COMPANY OVERVIEW
TABLE 298
BIOTRONIK: PRODUCTS OFFERED
TABLE 299
BIOTRONIK: EXPANSIONS: JANUARY 2022–MAY 2025
TABLE 300
TELEFLEX INCORPORATED: COMPANY OVERVIEW
TABLE 301
TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 302
TELEFLEX INCORPORATED: DEALS, JANUARY 2022–MAY 2025
TABLE 303
ACUTUS MEDICAL, INC.: COMPANY OVERVIEW
TABLE 304
ACUTUS MEDICAL, INC.: PRODUCTS OFFERED
TABLE 305
ACUTUS MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025
TABLE 306
MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
TABLE 307
MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
TABLE 308
MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2022–MAY 2025
TABLE 309
OSYPKA MEDICAL: COMPANY OVERVIEW
TABLE 310
OSYPKA MEDICAL: PRODUCTS OFFERED
TABLE 311
COOK: COMPANY OVERVIEW
TABLE 312
COOK: PRODUCTS OFFERED
TABLE 313
EPMAP-SYSTEM: COMPANY OVERVIEW
TABLE 314
CATHRX LTD.: COMPANY OVERVIEW
TABLE 315
EP SOLUTIONS: COMPANY OVERVIEW
TABLE 316
CATHVISION: COMPANY OVERVIEW
TABLE 317
TZ MEDICAL, INC.: COMPANY OVERVIEW
TABLE 318
APN HEALTH, LLC: COMPANY OVERVIEW
TABLE 319
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
TABLE 320
CARDIOFOCUS: COMPANY OVERVIEW
TABLE 321
SCHWARZER CARDIOTEK: COMPANY OVERVIEW
TABLE 322
IMRICOR: COMPANY OVERVIEW
LIST OF FIGURES
FIGURE 1
ELECTROPHYSIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
ELECTROPHYSIOLOGY MARKET: YEARS CONSIDERED
FIGURE 3
ELECTROPHYSIOLOGY MARKET: RESEARCH DESIGN
FIGURE 4
ELECTROPHYSIOLOGY MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
ELECTROPHYSIOLOGY MARKET: KEY PRIMARY SOURCES (SUPPLY AND DEMAND SIDES)
FIGURE 6
ELECTROPHYSIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 7
BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 8
BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
FIGURE 9
ELECTROPHYSIOLOGY MARKET: INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 10
ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (REVENUE SHARE ANALYSIS)
FIGURE 11
MARKET REVENUE ESTIMATION OF MEDTRONIC (2024)
FIGURE 12
ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE ANALYSIS
FIGURE 13
ELECTROPHYSIOLOGY MARKET: BOTTOM-UP APPROACH
FIGURE 14
ELECTROPHYSIOLOGY MARKET: TOP-DOWN APPROACH
FIGURE 15
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ELECTROPHYSIOLOGY MARKET
FIGURE 16
ELECTROPHYSIOLOGY MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 17
ELECTROPHYSIOLOGY MARKET: DATA TRIANGULATION METHODOLOGY
FIGURE 18
ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 19
ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 20
ELECTROPHYSIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 21
ELECTROPHYSIOLOGY MARKET: REGIONAL SNAPSHOT
FIGURE 22
RISING INCIDENCE OF CARDIOVASCULAR DISORDERS TO DRIVE MARKET
FIGURE 23
US AND ELECTROPHYSIOLOGY ABLATION CATHETERS ACCOUNTED FOR LARGEST NORTH AMERICAN MARKET SHARE IN 2024
FIGURE 24
ASIA PACIFIC TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 25
CHINA AND INDIA TO ACCOUNT FOR HIGHEST GROWTH RATES FROM 2025 TO 2030
FIGURE 26
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 27
ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 28
ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 29
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 30
KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY END USERS
FIGURE 31
TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015–JUNE 2025)
FIGURE 32
TOP APPLICANT COUNTRIES/REGIONS FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015–JUNE 2025)
FIGURE 33
ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS
FIGURE 34
ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 35
ELECTROPHYSIOLOGY MARKET: ECOSYSTEM ANALYSIS
FIGURE 36
ADJACENT MARKETS TO ELECTROPHYSIOLOGY MARKET
FIGURE 37
ELECTROPHYSIOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 38
ELECTROPHYSIOLOGY MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024
FIGURE 39
ELECTROPHYSIOLOGY MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 40
NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT
FIGURE 41
ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT
FIGURE 42
REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2020−2024)
FIGURE 43
MARKET SHARE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2024)
FIGURE 44
ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 45
ELECTROPHYSIOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 46
ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 47
EV/EBITDA OF KEY VENDORS
FIGURE 48
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 49
ELECTROPHYSIOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 50
ELECTROPHYSIOLOGY MARKET: R&D ASSESSMENT OF KEY PLAYERS, 2022–2024
FIGURE 51
JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
FIGURE 52
ABBOTT: COMPANY SNAPSHOT
FIGURE 53
MEDTRONIC: COMPANY SNAPSHOT
FIGURE 54
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 55
GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 56
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 57
JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT
FIGURE 58
STEREOTAXIS, INC.: COMPANY SNAPSHOT
FIGURE 59
MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 60
TELEFLEX INCORPORATED: COMPANY SNAPSHOT
FIGURE 61
ACUTUS MEDICAL, INC.: COMPANY SNAPSHOT
FIGURE 62
MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
Methodology
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
This research study used widespread secondary sources, such as directories, databases such as Dun & Bradstreet, Bloomberg BusinessWeek, and Factiva, white papers, annual reports, and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global pulse oximeters market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends, to the bottom-most level, geographic markets, and key developments related to the market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pulse oximeters market. The primary sources from the demand side include key executives from hospitals, physicians, clinicians, and research institutes.
A breakdown of the primary respondents is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In this report, the electrophysiology market size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the electrophysiology market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.
Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:
- Generating a list of major global players operating in the electrophysiology market.
- Mapping annual revenues generated by major global players from the Electrophysiology market(or nearest reported business unit/product category)
- Revenue mapping of key players to cover a major share of the global market, as of 2024
- Extrapolating the global value of the electrophysiology market
Global Electrophysiology Market Size: Top-Down & Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the Electrophysiology market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the electrophysiology market was validated using both top-down and bottom-up approaches.
Market Definition
An electrophysiology (EP) test is performed to examine the electrical activities and pathways of the patient’s heart in order to diagnose and treat complex cardiac conditions. It helps electrophysiologists identify the causes of heart rhythm disorders and determine the appropriate treatment. Electrophysiology (EP) refers to the study of the heart’s electrical system to analyze and diagnose its electrical functions. Cardiac electrophysiology studies the phenomena by recording the electrical activities of the heart with an invasive catheter. This testing is useful for evaluating complex arrhythmias or heart rhythm problems.
Stakeholders
- Electrophysiology devices manufacturing companies
- Suppliers and distributors of electrophysiology products
- Third-party refurbishers/suppliers
- Hospitals
- Cardiac Centers
- Ambulatory surgery centers
- Group purchasing organizations (GPOs)
- Medical research laboratories
- Academic medical centers and universities
- Venture capitalists
- Government bodies
- Corporate entities
- Market research and consulting firms
- Accountable care organizations
- Community centers
- Regulatory authorities.
- Business research and consulting service providers
- Raw material suppliers
Report Objectives
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To define, describe, segment, and forecast the electrophysiology market by product, indication, end user, and region
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To analyze micro markets concerning individual growth trends, prospects, and contributions to the overall electrophysiology market.
- To forecast the size of the electrophysiology market in five main regions, along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players in the electrophysiology market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the electrophysiology market
- To benchmark players within the electrophysiology market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Frequently Asked Questions (FAQ)
What is the expected addressable market value of the global Electrophysiology market over five years?
The global Electrophysiology market is expected to reach USD 21.72 billion by 2030 from USD 12.55 billion in 2025, at a CAGR of 11.6% during the forecast period.
Which segment-based products & services are expected to garner the highest traction within the Electrophysiology market?
The product segment is expected to grow at the highest rate.
What are the strategies adopted by the top market players to penetrate emerging regions?
The major players in the market use partnerships, distribution agreements, product launches, and product approvals as important growth tactics.
What are the major factors expected to limit the growth of the Electrophysiology market?
Infrastructural challenges in healthcare, affordability, and accessibility of treatments are the major challenges the market faces.
Which segment, based on Indication, is expected to garner the highest traction within the Electrophysiology market?
The atrial fibrillation segment is expected to grow at the highest rate.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Electrophysiology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Electrophysiology Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Electrophysiology Market